About this episode
Karen explores the expanding uses of GLP-1 receptor agonists beyond weight loss and diabetes.
Karen takes a look at GLP-1 receptor agonists, best known for weight loss and diabetes. She explores the rapidly expanding list of conditions these medications may help treat. From emerging and sometimes conflicting research on Parkinson’s and Alzheimer’s disease to FDA-approved benefits for cardiovascular health, kidney disease, and fatty liver disease, Karen breaks down what the science currently shows and where caution is still needed. Visit our website itchyandbitchy.com to read blog posts on the many topics we have covered on the show.
People in this episode
Host: Karen Nickell
Topics covered
- GLP-1
- weight loss
- diabetes
- Parkinson’s disease
- Alzheimer’s disease
- cardiovascular health
- kidney disease
Keywords
- GLP-1
- weight loss
- diabetes
- Parkinson’s
- Alzheimer’s
- cardiovascular health
- kidney disease
- fatty liver disease
Mentioned in this episode
Products: GLP-1 receptor agonists
More episodes of Itchy and Bitchy
- 219: A Perfect Birth… Then a Deadly Heart Attack · June 6, 2026 · 27 min
- 218: Itchy and Bitchy ClinicCrawl - Give the medicine, Respect the worms; Vomiting LungWorms · June 1, 2026 · 8 min
- 217: Healthcare Is a Dumpster Fire with Better Branding but the System Still Sucks! · May 25, 2026 · 31 min
- Life Transitions: Karen and Forrest's Exit - Itchy and Bitchy · May 16, 2026 · 40 min
- Estrogen Has Been Let Out of Jail! - Itchy and Bitchy · May 2, 2026 · 48 min
- Dining with Your Dog: No Kibble Needed - Itchy and Bitchy · April 18, 2026 · 30 min
Explore listener stats, chart rankings, contacts and more on the Itchy and Bitchy podcast page.